Oncolytics Biotech(ONCY)
$0.37-0.00 (-0.54%)
ONCY
Oncolytics Biotech financials statements
$0.37
At close:-0.00 (-0.54%)
Want to see ONCY full AI Analyst Report?
Oncolytics Biotech (ONCY) Income Statement
1,677 Followers
Oncolytics Biotech Income Statement
Last quarter (Q3 2026), Oncolytics Biotech's total revenue was C$0.00. In Q3, Oncolytics Biotech's net income was C$-9.71M. See Oncolytics Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ 28.73M | C$ 25.54M | C$ 25.47M | C$ 19.84M | C$ 26.23M | |
| Depreciation and Amortization | C$ 70.00K | C$ 87.00K | C$ 303.78K | C$ 288.83K | C$ 452.00K |
| C$ -28.66M | C$ -25.45M | C$ -25.17M | C$ -19.55M | C$ -25.78M | |
| C$ -28.73M | C$ -25.54M | C$ -25.47M | C$ -19.84M | C$ -26.23M | |
| C$ 45.00K | C$ 2.84M | C$ 4.63M | C$ 1.60M | C$ -20.05K | |
| C$ -28.68M | C$ -22.70M | C$ -20.85M | C$ -18.24M | C$ -26.25M | |
| C$ -28.76M | C$ -22.79M | C$ -20.92M | C$ -18.30M | C$ -26.30M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.41 | C$ -0.30 | C$ -0.41 | C$ -0.44 | C$ -0.49 |
| Diluted EPS | C$ -0.41 | C$ -0.30 | C$ -0.41 | C$ -0.44 | C$ -0.49 |
| Weighted Average Shares Outstanding | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M |
| Weighted Average Shares Outstanding (Diluted) | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M |
Currency in CAD
